Malignant Brain Tumors: State-Of-The-Art Treatment

ISBN-13: 9783319842592 / Angielski / Miękka / 2018 / 297 str.

Jennifer Moliterno Gunel; Joseph M. Piepmeier; Joachim M. Baehring

Recenzje

"This textbook analyzes the dismal prognosis and very limited efficacy for single or multi agent therapy of Glioblastomas GBMs. ... I recommend this book to neurosurgeons and oncologists" (Joseph Grenier, Amazon.de, May, 2018)

"This succinct book is designed as a comprehensive, yet concise update on the contemporary treatment of gliomas. ... The audience includes neurosurgeons, neurologists, oncologists, and all practitioners with routine exposure to gliomas. ... This is a satisfactory update on the contemporary biology and treatment for neuro-oncology's enduring foe: gliomas. ... The book provides a succinct, effective research update for clinicians wishing to familiarize themselves with advances in the field over the last decade." (Darian Ross Esfahani, Doody's Book Reviews, April, 2017)

Spis treści

Part I: Molecular and Clinical Characterization of Gliomas.- The Use of Advanced Neuro-Imaging (fMRI, DTI/Tractography) in the Treatment of Malignant Gliomas.- Molecular Neuropathology and the Ontogeny of Malignant Gloimas.- Personalized Medicine through Advanced Genomics.- Part II: Surgery: Maximizing the Extent of Tumor Resection.- The Usefulness of Stereotactic Neuronavigation Along with Intraoperative Imaging in Malignant Brain Tumor Surgery.- Mapping the Brain for Primary Tumor Surgery.- Fluorescence-guided Resection of Malignant Gliomas.- The Rolse of Laser-Induced Thermal Therapy in the Management of Malignant Gliomas.- Part III: Adjuvant Therapies.- Current Standard Treatment Options of Malignant Glioma.- Targeting Aberrant Signaling Pathways.- Targeted Therapy of IDH1-mutated Tumors.- Antiangiogenic Therapy for Malignant Gliomas.- Immunotherapy for High-Grade Gliomas.- Novel Delivery Strategies.- Radiation Therapy for Malignant Gliomas: Current Options.- Glioma Radiosensitizers: Exciting New Developments and Directions.- Part IV: Tumor-Specific Approach: Oligodendroglioma (IDH1 mutated, 1p/19q deleted).- Glioblastoma.

O autorze

Joseph M Piepmeier, MD

Nixdorff-German Professor of Neurosurgery

Department of Neurosurgery

Yale University School of Medicine

New Haven, Connecticut

USA

Jennifer Moliterno Gunel, MD

Assistant Professor, Department of Neurosurgery

Section of Neurosurgical Oncology

Yale University School of Medicine

New Haven, Connecticut

USA

Joachim M. Baehring, MD, DSc.

Department of Neurology and Neurosurgery

Yale University School of Medicine

New Haven, Connecticut

USA